Can be according to method treatment of the present invention and any disease of becoming thin or inflammation is relevant, such as cardiovascular, periphery blood capillary, central nervous system, tumor, immunity and infectious disease state.Preferred described disease is selected from cancer, cachexia, relevant with the age becomes thin, with long-term be in hospital relevant become thin, HIV/AIDS, arthritis, wound, hepatopathy, Crohn disease or other inflammatory bowel (IBD), renal insufficiency and COPD (chronic obstructive pulmonary disease).More preferably described disease is a cachexia
Oxidative stress is a critical factor in inducing the release of chemokines from keratinocytes that direct CD8+ T cells and lead to migration into skin tissue, causing melanocyte death [20]
Scientists are unsure whether water retention can cause headaches, but headaches have been a reported symptom in those who reported suffering from water retention
As mentioned, some clinics have already started applying this NNMT inhibitor to humans, even though the FDA has made no ruling on its safety, making human trials paramount